Ida Hilden

Ida Hilden is currently the Corporate Project Vice President at Novo Nordisk since October 2014. Ida heads the LEAD Portfolio Projects and is a member of the Research and Early Development Leadership Team. Prior to this role, Ida served as the Director, Head of Haemophilia in vitro Biology at Novo Nordisk from 2004 to 2014. Overall, Ida has a strong background in biochemistry and research, as evidenced by their extensive experience in various research and project leadership roles within the biotechnology industry. Ida holds a Doctor of Philosophy (PhD) degree in Biochemistry from the University of Copenhagen.